Home/Hedge Fund Intelligence/Oric Pharmaceuticals, Inc.
Nasdaq: ORICStockForm 13F30 Jun 2026

Hedge funds that hold Oric Pharmaceuticals, Inc. Nasdaq: ORIC

CUSIP 68622P109 · who reports it, how much, and how much it matters to them

26 of the 720 hedge fund managers we track reported shares of Oric Pharmaceuticals, Inc. (Nasdaq: ORIC) on Form 13F for 30 June 2026. Between them they reported USD 350m. The largest position belongs to ECOR1 Capital, at USD 73m. The manager with the most riding on it is Aihc Capital Management, where it is 39.8% of the reported book.

Managers reporting it26of 720 we track
Value they reportUSD 350mshares only, 30 Jun 2026
Funds they run262with a file on PPLI.com
Largest positionUSD 73mECOR1 Capital
Typical weight0.0%median share of a manager's book
Heaviest weight39.8%Aihc Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

26 managers, USD 350m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Oric Pharmaceuticals, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1ECOR1 Capital3 funds on PPLI.comUSD 73m3.5%
2Viking Global Investors4 funds on PPLI.comUSD 56m0.2%
3Aihc Capital Management1 fund on PPLI.comUSD 41m39.8%
4Alkeon Capital Management19 funds on PPLI.comUSD 40m0.1%
5Citadel Advisors32 funds on PPLI.comUSD 28m0.0%
6Orbimed Advisors1 fund on PPLI.comUSD 22m0.4%
7D. E. Shaw & Co.15 funds on PPLI.comUSD 17m0.0%
8Braidwell12 funds on PPLI.comUSD 13m0.5%
9Adage Capital Management1 fund on PPLI.comUSD 11m0.0%
10Sphera Funds Management1 fund on PPLI.comUSD 8.2m1.1%
11Millennium Management6 funds on PPLI.comUSD 7.6m0.0%
12Two Sigma Investments35 funds on PPLI.comUSD 6.5m0.0%
13Arrowmark Colorado Holdings24 funds on PPLI.comUSD 6.3m0.3%
14Superstring Capital Management1 fund on PPLI.comUSD 4.4m2.8%
15Redmile Group10 funds on PPLI.comUSD 3.9m0.3%
16Boxer Capital Management1 fund on PPLI.comUSD 3.8m0.3%
17Squarepoint Ops7 funds on PPLI.comUSD 3.7m0.0%
18Atom Investors1 fund on PPLI.comUSD 1.4m0.1%
19Engineers Gate Manager1 fund on PPLI.comUSD 694,0000.0%
20Tudor Investment Corporation10 funds on PPLI.comUSD 459,0000.0%
21LMR Partners2 funds on PPLI.comUSD 382,0000.0%
22Brevan Howard Capital Management39 funds on PPLI.comUSD 332,0000.0%
23Balyasny Asset Management25 funds on PPLI.comUSD 262,0000.0%
24Jain Global1 fund on PPLI.comUSD 191,0000.0%
25The Quarry1 fund on PPLI.comUSD 182,0000.0%
26Prelude Capital Management9 funds on PPLI.comUSD 122,0000.0%
Next: where it matters most
Where it matters most

For Aihc Capital Management it is 39.8% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Aihc Capital ManagementUSD 41m39.8%
2ECOR1 CapitalUSD 73m3.5%
3Superstring Capital ManagementUSD 4.4m2.8%
4Sphera Funds ManagementUSD 8.2m1.1%
5BraidwellUSD 13m0.5%
6Orbimed AdvisorsUSD 22m0.4%
7Boxer Capital ManagementUSD 3.8m0.3%
8Arrowmark Colorado HoldingsUSD 6.3m0.3%
9Redmile GroupUSD 3.9m0.3%
10Viking Global InvestorsUSD 56m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Oric Pharmaceuticals, Inc.

What is the ticker symbol of Oric Pharmaceuticals, Inc.?

Oric Pharmaceuticals, Inc. trades under the symbol ORIC on the Nasdaq. Its CUSIP, the code used on Form 13F, is 68622P109.

Which hedge funds own Oric Pharmaceuticals, Inc. (Nasdaq: ORIC)?

26 of the 720 hedge fund managers PPLI.com tracks reported Oric Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by ECOR1 Capital (USD 73m), Viking Global Investors (USD 56m), Aihc Capital Management (USD 41m), Alkeon Capital Management (USD 40m) and Citadel Advisors (USD 28m).

How many hedge funds hold Oric Pharmaceuticals, Inc.?

26 managers in our coverage reported it, and between them they run 262 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Oric Pharmaceuticals, Inc.?

Aihc Capital Management, where the position was 39.8% of the reported 13F book at 30 June 2026.

Does this show who is short Oric Pharmaceuticals, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Oric Pharmaceuticals, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.